leadXpro
“We unlock tomorrow’s medicines together, better, faster.”
At leadXpro, we are committed to accelerating the discovery of life-changing medicines. Driven by our passion for innovation and cutting-edge science, we specialize in structure-based drug discovery, with a laser focus on membrane proteins. Working together with our clients, we aim to transform our science into therapies—better and faster.

Team




Founders

Gebhard Schertler
Expert, Membrane Protein Science
Biochemist, department head BIO and member of the Directorial Board of the Paul Scherrer Institue PSI

Michael Hennig
CEO and Chairman of the Board
Structural biologist and senior drug discovery executive. Previously, global leader discovery technologies at Roche.

Rafael Abela
Technology Expert, Board Member
Physicist at the PSI, scientific project leader for the SLS and SwissFEL projects.
Board of Directors
Michael Milos
Board Member
Molecular Biologist, life-cycle management in drug development at Actelion, project management at Vaxxilon and co-founder of AVANTECA Partners.
John Millard
Board Member
Chemical engineering, MBA at London Business School, positions at BP, ABB, Enron and other companies, co-founder of two companies. Since 2018 Head of Technology Transfer Management at PSI.
Andreas Insam
Board Member
Doctor in political economics, University of Innsbruck. Previously CEO of Bendura Bank, previously Board member of LGT Bank.
- Michael Hennig as Chairman of the Board
- Rafael Abela as Board Member